Jamie Gowryluk - Medicure VP Operations
| MCUJF Stock | USD 0.70 0.02 2.94% |
Insider
Jamie Gowryluk is VP Operations of Medicure
| Phone | 204 487 7412 |
| Web | https://www.medicure.com |
Medicure Management Efficiency
The company has return on total asset (ROA) of 0.021 % which means that it generated a profit of $0.021 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1483 %, meaning that it generated $0.1483 on every $100 dollars invested by stockholders. Medicure's management efficiency ratios could be used to measure how well Medicure manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Yiftach Roth | Brainsway | 53 | |
| Nikolai Kabelev | STRATA Skin Sciences | 48 | |
| Janelle Strop | Tactile Systems Technology | N/A | |
| Soren Sinay | Venus Concept | 53 | |
| Shunichi Kuroda | Bone Biologics Corp | N/A | |
| Darrell Rigel | STRATA Skin Sciences | 73 | |
| Domenic Penna | Venus Concept | 62 | |
| Aron Tendler | Brainsway | N/A | |
| William MBA | STRATA Skin Sciences | 58 | |
| Robert Moccia | STRATA Skin Sciences | 65 | |
| Victoria Vezina | Rapid Micro Biosystems | 56 | |
| Ronen CPA | Icecure Medical | 55 | |
| Shay Levav | Icecure Medical | 47 | |
| MD ODonnell | Tactile Systems Technology | N/A | |
| Rajiv Silva | Venus Concept | 57 | |
| Sunday Hoy | Tactile Systems Technology | N/A | |
| Veronica Cai | Tivic Health Systems | 48 | |
| Jonathan Paris | Rapid Micro Biosystems | 48 | |
| Richard Ginn | Tenon Medical | 58 | |
| Michael Goodman | STRATA Skin Sciences | N/A | |
| Jennifer Ernst | Tivic Health Systems | 56 | |
Management Performance
| Return On Equity | 0.15 | |||
| Return On Asset | 0.021 |
Medicure Leadership Team
Elected by the shareholders, the Medicure's board of directors comprises two types of representatives: Medicure inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medicure. The board's role is to monitor Medicure's management team and ensure that shareholders' interests are well served. Medicure's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medicure's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Neil Owens, President COO | ||
| CPA BCom, Chief Officer | ||
| Albert Friesen, Founder, Chairman and CEO | ||
| Jamie Gowryluk, VP Operations | ||
| Reuben Saba, VP Affairs |
Medicure Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Medicure a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.15 | |||
| Return On Asset | 0.021 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 5.67 M | |||
| Shares Outstanding | 10.25 M | |||
| Shares Owned By Insiders | 26.70 % | |||
| Shares Owned By Institutions | 23.51 % | |||
| Number Of Shares Shorted | 15.08 K | |||
| Price To Earning | 11.45 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Medicure Pink Sheet
Medicure financial ratios help investors to determine whether Medicure Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medicure with respect to the benefits of owning Medicure security.